INFORMED.
LIVE

Metropolis Healthcare Limited

BSE: METROPOLIS542650ISIN INE112L01020
  • Healthcare
  • Healthcare Service Provider
  • BSE 1000

Share price

₹597.55+12.25 (+2.09%)
as of 18 Sep 2026
Metropolis Healthcare Limited share price, 18 Sep 2025 to 18 Sep 2026: ₹2,045.65 to ₹597.55 (-70.8%). Low ₹423.80, high ₹2,111.75. Volume shown below the price.
52W high
₹2,162.45
52W low
₹413.00
Off 52W high
-72.37%
1M return
+7.54%
3M return
+8.21%
6M return
+36.01%
1Y return
-70.79%
20D avg volume
83,675
50 DMA
₹573.38
200 DMA
₹1,060.86

Key ratios Consolidated

Market cap
₹12,392 Cr
Current price
₹597.55
52W high / low
₹2,162.45 / ₹413.00
Face value
₹2.00
P/E
61.08
P/B
EPS (TTM)
₹9.78
Book value / share
ROE
ROCE
15.70%
Operating margin
Net margin
Debt / equity
0.01
Net debt
₹-36.05 Cr
Interest cover
11.56
Dividend yield
0.84%
Dividend / share (TTM)
₹5.00
Payout
51.12%
Cash conversion cycle
19.2 days

About

In plain English

Metropolis Healthcare is a chain of diagnostic labs that runs medical tests—like blood work, genetic screening, and health check-ups—for patients and healthcare providers across India and Kenya. When your doctor orders a test, you visit one of their 219 labs or 4,800 collection centres; they then analyse the sample and send back a report. Their TruHealth packages bundle preventive checks (ECG, vitals, radiology) and use an AI tool called MetAdvisor to recommend upgrades. They also offer advanced specialty tests in oncology, genomics (via a new Illumina partnership), and AI-driven diagnostics like allergy testing. Customers include individual patients (60% of revenue), plus hospitals, corporate clients, government agencies, and clinical trial sponsors (40% of revenue).

AI-generated summary, written from the company's own filings and disclosures. Every figure elsewhere on this page comes from exchange data, not from a model. See our editorial standards. Generated 5 Jul 2026.

Financials

MetricQ1 FY27Q4 FY26Q3 FY26Q2 FY26Q1 FY26Q4 FY25Q4 FY24
Income statement
450.21424.68405.91429.19386.06345.29
5.108.169.020.897.526.97
377.61363.19348.67359.06332.35316.22
87.1078.4879.2487.7579.0571.53
0.000.000.000.000.000.00
106.9895.4794.2295.3992.2882.19
6.187.935.735.685.204.60
32.4038.5931.8832.4130.8528.62
144.94142.71137.60137.83124.98129.27
77.7169.6666.2571.0361.2336.04
0.000.11-9.100.000.000.00
77.7169.7657.1671.0361.2336.04
20.8318.8015.0718.1415.996.81
56.8850.9642.0952.8945.2529.23
2.732.467.9910.178.705.69
Key metrics
116.29116.2894.77109.1297.2869.26
25.80%27.40%23.30%25.40%25.20%20.10%
12.60%12.00%10.40%12.30%11.70%8.50%
4.30%4.50%2.60%
16.60%23.00%
25.70%74.30%
MetricTTMFY26FY25FY24
Income statement
1,7101,6461,331
23.1725.5815.11
1,4491,4031,155
332.57324.52268.68
0.000.000.00
392.06377.36313.75
25.5224.5418.57
135.28133.72108.68
563.08543.12445.77
284.65268.17190.85
-8.99-8.990.00
275.66259.18190.85
72.8467.9945.34
202.82191.18145.51
23.359.1928.29
Key metrics
436.46417.44318.10
25.52%25.40%23.90%
11.86%11.60%10.90%
15.70%13.30%
23.60%
31.40%
307.21219.34
1.831.81
0.010.01
-36.05-25.29
19.219.2
Balance sheet
2,1381,867
468.61345.94
54.7839.48
170.29147.95
45.4947.84
37.1924.61
215.30190.26
129.42125.86
334.02294.33
18.7314.19
18.738.92
0.005.27
1,5251,335
Cash flow
350.70262.75
-223.12-201.06
-115.29-86.63
43.4943.41
MetricQ1 FY27Q4 FY26Q3 FY26Q2 FY26Q1 FY26Q4 FY25Q4 FY24
Income statement
372.28352.03334.78355.71323.63311.95
5.198.822.222.522.787.60
311.09301.24286.72296.11278.73290.91
68.4760.8262.3368.2161.3664.13
0.000.000.000.000.000.00
85.2474.9374.9175.4672.3368.69
4.776.564.373.974.294.43
27.8132.8027.7227.7927.8627.28
124.80126.13117.39120.69112.88126.38
66.3859.6150.2862.1247.6828.64
0.000.00-7.960.000.000.00
66.3859.6142.3262.1247.6828.64
15.7216.3510.2915.4912.104.78
50.5843.2432.0346.6335.5823.85
2.442.096.189.006.874.65
Key metrics
98.9698.9774.4193.8879.8360.35
26.60%28.10%22.20%26.40%24.70%19.30%
13.60%12.30%9.60%13.10%11.00%7.60%
4.10%4.40%2.30%
15.00%12.80%
42.20%81.30%
MetricTTMFY26FY25FY24
Income statement
1,4151,3651,217
18.7516.3317.05
1,1951,1631,072
259.83252.72244.49
0.000.000.00
310.54297.44271.98
19.6719.1918.26
116.12116.17104.89
489.01477.09431.95
238.39219.20162.02
-7.96-7.960.00
230.43211.24162.02
57.8554.1037.23
172.48157.48124.80
19.717.6224.35
Key metrics
366.22346.60285.17
25.88%25.40%23.40%
12.19%11.50%10.30%
14.40%12.50%
12.20%
26.20%
317.89236.48
2.022.20
0.000.00
-20.06-22.68
9.611.5
Balance sheet
1,8701,685
346.19256.12
20.0622.68
118.87113.67
32.2131.55
27.6213.82
174.80168.69
115.27107.06
265.41245.08
0.000.00
0.000.00
0.000.00
1,3891,244
Cash flow
317.89275.01
-209.05-196.09
-111.18-84.50
0.0038.53

Compounded growth

Standalone

Sales CAGR 3Y
Sales CAGR 5Y
Sales CAGR 10Y
Profit CAGR 3Y
Profit CAGR 5Y
Profit CAGR 10Y
Sales YoY (TTM)
Profit YoY (TTM)

Consolidated

Sales CAGR 3Y
Sales CAGR 5Y
Sales CAGR 10Y
Profit CAGR 3Y
Profit CAGR 5Y
Profit CAGR 10Y
Sales YoY (TTM)
Profit YoY (TTM)

Compounded from reported annual figures. We publish no share-price CAGR: our prices are as-traded, so one would be wrong across every split and bonus issue.

Shareholding as of 30 Jun 2026

Promoter holding
48.86%
HolderTypeHoldingPreviousChange
Metz Advisory LLPPromoter30.27%
Duru Shah Family Trust (Duru Sushil Shah & Sushil Kanubhai Shah)Promoter Group11.05%
Hdfc Mutual Fund - Hdfc Focused FundPublic9.66%
Sushil Shah Family Trust (Sushil Kanubhai Shah & Duru Sushil Shah)Promoter7.19%
Franklin India Small Cap FundPublic4.24%
Kotak Small Cap FundPublic3.79%
Uti-Large Cap FundPublic3.72%
Tata Business Cycle FundPublic2.84%
Nippon Life India Trustee Ltd-A/C Nippon India Small Cap FundPublic2.21%
Aditya Birla Sun Life Trustee Private Limited A/C Aditya Birla Sun Life Flexi Cap FundPublic1.95%
Canara Robeco Mutual Fund A/C Canara Robeco Small Cap FundPublic1.45%
Ameera Sushil ShahPromoter0.35%
Chogori Distribution Private LimitedPromoter Group0.00%
Better OptionsPromoter Group0.00%
G&L Advisory LLPPromoter Group0.00%

Public shareholders are disclosed individually only above 1%.

Filings & corporate actions

Recent announcements

Corporate actions

PurposeEx dateRecord datePayment date
Interim Dividend - Rs. - 1.000019 May 202619 May 2026
Bonus issue 3:120 Mar 202620 Mar 2026
Interim Dividend - Rs. - 4.000011 Nov 202511 Nov 2025

Board meetings

  • Board Meeting - Financial Results

Coverage